Indian market to grow 20% this year; France tries DTC campaign for generics;

@FiercePharma: Stada exec says board would entertain the right offer. Report | Follow @FiercePharma

 @AlisonBFierce: Manufacturers already shipped more than 128M doses of flu vaccine--nearly 95% of the 135M doses made this season. More | Follow @AlisonBFierce

> France is asking the European Medicines Agency to add labeling warnings to newer contraceptives over concerns of higher risks of blood clots. Story

> A report by Morgan Stanley says India's drug market could grow nearly 20% this year as early investments start to provide results. Item

> Canadian pharmacy chain Jean Coutu Group said sales of its generic drug line have lifted its quarterly profit 10%. Story

> Gilead Sciences ($GILD) is being criticized by HIV support groups for having moved prices up on a number of its most-used drugs. Story

Medical Device News

 @FierceMedDev: Bayer gains FDA nod for long-use IUD. Story | Follow @FierceMedDev

@MarkHFierce: A Swiss Dx company focused on nanotech brought in $3M in new Series A financing. Article | Follow @MarkHFierce

 @DamianFierce: $LLY's jumping back on the companion diagnostics bandwagon with a new Dako partnership. Report | Follow @DamianFierce

> Medtronic hunts for expanded pacer indication with large study. Story

> As of July 1, Malaysia mandates device product registration. Item

Biotech News

 @FierceBiotech: J&J's diabetes drug passes FDA panel test despite safety concerns. Story | Follow @FierceBiotech

@RyanMFierce: Another failure for tivantinib $ARQL. Ph2 in colon cancer after PhIII fiasco in lung cancer last year. | Follow @RyanMFierce

> GSK rests hopes on R&D pipeline after tough 2012. Article

> ArQule, Daiichi cough up another failure for lead cancer drug. Story

And Finally... A three-week direct-to-consumer campaign to boost confidence in generic drugs is kicking off in France where only about 25% of prescriptions are for generics, compared with about 80% in the U.S. Story

Suggested Articles

With U.S. presidential and congressional campaigns in full swing, it’s not just Americans anxiously awaiting the results of the upcoming elections.

Sun Pharma has recalled one lot of its generic metformin after finding high levels of the probable carcinogen NDMA in tested lots.

Six months after WHO declared a pandemic, the list of drugs proven to work against the virus remains short. Now, Fujifilm has added its drug Avigan.